Professor of Neurology, Barts & The London. MS & Preventive Neurology thinker, blogger, runner, vegetable gardener, husband, father, cook and wine & food lover.
Notify me of follow-up comments by email.
Notify me of new posts by email.
Good to see a bona fide trial even if very small in terms of participants. Some commments / thoughts:
– I'm not sure if the trial used immunosuppression before the stem cells were injected?
– I'm not sure how this differs from Prof Freedman's approach in Canada?
– when stem cells started to look promising as a potential treatment, it was for repairing damage i.e. replacing neurons / axons etc. Now the focus seems to be on addressing the immune system and neuro-protection. Is repair (leading to reversal of established disability) no longer seen as a potential benefit which stem cells treatments can provide?